Marriott Stock Up as Q3 Earnings Beat Estimates, RevPAR Rises Y/Y — Positive
MAR Zacks Investment Research — November 04, 2025MAR's third-quarter earnings and revenues beat estimates as strong global demand and luxury segment gains lift results.
Norwegian Q3 Earnings Beat, Revenues Miss Estimates, Stock Down — Positive
NCLH Zacks Investment Research — November 04, 2025NCLH beat third-quarter earnings estimates but missed on revenues, with shares sinking 9% despite record occupancy and strong demand.
NASDAQ: QURE Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm — Neutral
QURE Business Wire — November 04, 2025RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of uniQure N.V. (NASDAQ: QURE) (“uniQure”). On November 3, 2025, uniQure issued a press release revealing that the FDA notified the company that data for its AMT-130, an investigational gene therapy for Huntington's disease, did not provide sufficient evidence to support uniQure's Biologics Licen.
Law Offices of Frank R. Cruz Encourages James Hardie Industries plc (JHX) Shareholders To Inquire About Securities Fraud Class Action — Neutral
JHX Business Wire — November 04, 2025LOS ANGELES--(BUSINESS WIRE)--Law Offices of Frank R. Cruz Encourages James Hardie Industries plc (JHX) Shareholders To Inquire About Securities Fraud Class Action.
Norway wealth fund to oppose Elon Musk's $1T Tesla pay package — Negative
TSLA Proactive Investors — November 04, 2025Norway's sovereign wealth fund announced on Tuesday that it will vote against Tesla Inc (NASDAQ:TSLA) CEO Elon Musk's proposed compensation package at the company's annual shareholder meeting on November 6. The package is contingent on Tesla achieving ambitious milestones over the next decade, including growing the company's market value to $8.5 trillion.
Gold, silver down as USDX hits 6-mo. high — Negative
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL SIL SILJ SIVR SLV SLVP UGL Kitco — November 04, 2025Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.
WPP INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of WPP — Neutral
WPP GlobeNewsWire — November 04, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $10,000 In WPP To Contact Him Directly To Discuss Their Options
FLYE DEADLINE NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Fly-E Group, Inc. Investors to Secure Counsel Before Important November 10 Deadline in Securities Class Action – FLYE — Neutral
FLYE GlobeNewsWire — November 04, 2025NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fly-E Group, Inc. (NASDAQ: FLYE) between July 15, 2025 and August 14, 2025, both dates inclusive (the “Class Period”), of the important November 10, 2025 lead plaintiff deadline.
MRX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Marex Group — Neutral
MRX GlobeNewsWire — November 04, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $10,000 In Marex To Contact Him Directly To Discuss Their Options
Investors Still Lovin' McDonald's? Bull Case Perspective Into MCD Earnings — Positive
MCD Schwab Network — November 04, 2025McDonald's (MCD) will offer a clearer picture not just for the state of the company, but also for the fast-food industry. Brian Szytel believes the set-up looks good heading into the report as it mitigates labor woes.
INOD Stock Ahead of Q3 Earnings: Time to Add or Stay Cautious? — Neutral
INOD Zacks Investment Research — November 04, 2025Innodata to post third-quarter results on Nov. 6, with strong AI-driven revenue momentum but margin pressure from growth investments.
Take-Two to Report Q2 Earnings: What's in the Cards for the Stock? — Positive
TTWO Zacks Investment Research — November 04, 2025TTWO is poised for strong fiscal Q2 results with blockbuster game launches like NBA 2K26 and Borderlands, which are expected to drive bookings growth.
IREN Limited: $9.7B Microsoft Catalyst, But I Remain Cautious Into Q1 On Dilution Risk — Positive
MSFT Seeking Alpha — November 04, 2025My bull case revolves around the 2 GW Sweetwater hub, which could expand GPU capacity by 30x, while the $9.7B Microsoft deal drives momentum in the AI cloud segment. Microsoft prepays 20% (~$2B) on a 5-year contract. In exchange, IREN will buy $5.8B of Dell systems, adding 200 MW at Childress through 2026. Funding is tight. The $1B ATM program is already depleted. The $1B raised in convertible notes, plus Microsoft's $2B prepayment, still leaves a $1.8B gap to meet the Dell commitment.
BOXABL and FG Merger II Corp. Extend Outside Date for Completion of Proposed Merger — Neutral
FGMC PRNewsWire — November 04, 2025LAS VEGAS and ITASCA, Ill. , Nov. 4, 2025 /PRNewswire/ -- Boxabl Inc. ("BOXABL"), a leader in innovative housing solutions, and FG Merger II Corp. ("FGMC") (Nasdaq: FGMC), a publicly traded special purpose acquisition company, today announced that they have signed an amendment (the "Amendment") to their previously announced Agreement and Plan of Merger (the "Merger Agreement") for a merger between the two companies.
Federated Hermes: Staying Bullish With Q3 Outperformance And Latest M&A — Positive
FHI Seeking Alpha — November 04, 2025Federated Hermes's 3Q25 top-line and bottom-line beat the consensus forecasts by +5% and +20%, respectively. FHI's acquisition of FCP Fund Manager broadens its U.S. real estate presence, boosts diversification efforts, and is expected to be margin-accretive. The 4Q2025 outlook for FHI remains positive, considering management's disclosures regarding a robust pipeline.
FLYE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fly-E Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
FLYE GlobeNewsWire — November 04, 2025NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Fly-E Group, Inc. (“Fly-E” or “the Company”) (NASDAQ: FLYE) and certain of its officers.
DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
DXCM GlobeNewsWire — November 04, 2025NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against DexCom, Inc. (“DexCom” or “the Company”) (NASDAQ: DXCM) and certain of its officers.
Aardvark Therapeutics Presents Data Supporting its Metabolic Obesity Pipeline Programs at ObesityWeek 2025 — Neutral
AARD GlobeNewsWire — November 04, 2025New preclinical results demonstrate the potential of ARD-201 in enhanced glucose control, along with preservation of lean mass, underscoring its opportunity in addressing key challenges in today's obesity treatment landscape Preclinical and clinical data demonstrates the potential of ARD-201 to attenuate weight gain, promote weight loss and help maintain weight after the discontinuation of GLP-1RA Aardvark to host investor webinar on November 5th, 2025 to review ARD-101 and ARD-201 programs, as well as ObesityWeek presentations SAN DIEGO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to …
Omada Health to Present Real-World Evidence at ObesityWeek 2025 Demonstrating Enhanced Outcomes for Current and Former GLP-1 Users — Neutral
OMDA GlobeNewsWire — November 04, 2025SAN FRANCISCO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, announced it will present two posters at ObesityWeek 2025 highlighting the potential impact of Omada's behavior change program on members currently or previously on GLP-1 medications for weight loss. Together, these analyses suggest that engagement with Omada may enhance results for members who have been on GLP-1s for weight loss, whether they stay on the medication or not.
Chemed Corporation to Present at the UBS 2025 Global Healthcare Conference — Neutral
CHE GlobeNewsWire — November 04, 2025CINCINNATI, Ohio, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the UBS 2025 Global Healthcare Conference on Tuesday, November 11, 2025, at approximately 2:00 p.m. (ET) at the PGA National Resort in Palm Beach Gardens, Florida.